Publication:
Identification of three novel natural product compounds that activate PXR and CAR and inhibit inflammation

dc.contributor.authorSuticha Kittayaruksakulen_US
dc.contributor.authorWenchen Zhaoen_US
dc.contributor.authorMeishu Xuen_US
dc.contributor.authorSongrong Renen_US
dc.contributor.authorJing Luen_US
dc.contributor.authorJu Wangen_US
dc.contributor.authorMichael Downesen_US
dc.contributor.authorRonald M. Evansen_US
dc.contributor.authorRaman Venkataramananen_US
dc.contributor.authorVaranuj Chatsudthipongen_US
dc.contributor.authorWen Xieen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Pittsburghen_US
dc.contributor.otherCapital Medical University Chinaen_US
dc.contributor.otherSalk Institute for Biological Studiesen_US
dc.date.accessioned2018-10-19T04:36:28Z
dc.date.available2018-10-19T04:36:28Z
dc.date.issued2013-09-01en_US
dc.description.abstractPurpose: To investigate the effects of three natural product compounds, carapin, santonin and isokobusone, on the activity of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) in induction of drug-metabolizing enzymes and inhibition of inflammation. Methods: The monkey kidney-derived fibroblast (CV-1) cells and human embryonic kidney HEK293 cells were used for transient transfection and luciferase reporter gene assays. Human primary hepatocytes and primary hepatocytes from wild type, PXR-/-, and hPXR transgenic mice were used to study the induction of drug-metabolizing enzymes and the implication of these compounds in inflammation. Results: Carapin, santonin and isokobusone activated both PXR and CAR in transient transfection and luciferase reporter gene assays. Mutagenesis studies showed that two amino acid residues, Phe305 of the rodent PXR and Leu308 of the human PXR, are critical for the recognition of these compounds by PXR. Importantly, the activation of PXR and CAR by these compounds induced the expression of drug-metabolizing enzymes in primary human and mouse hepatocytes. Furthermore, activation of PXR by these compounds inhibited the expression of inflammatory mediators in response to lipopolysaccharide (LPS). The effects of these natural compounds on drug metabolism and inflammation were abolished in PXR-/- hepatocytes. Conclusions: Our results show that carapin, santonin and isokobusone activate PXR and CAR and induce drug-metabolizing enzymes. In addition, these compounds inhibited the expression of inflammatory mediators in response to LPS through the activation of PXR. © 2013 Springer Science+Business Media New York.en_US
dc.identifier.citationPharmaceutical Research. Vol.30, No.9 (2013), 2199-2208en_US
dc.identifier.doi10.1007/s11095-013-1101-9en_US
dc.identifier.issn1573904Xen_US
dc.identifier.issn07248741en_US
dc.identifier.other2-s2.0-84883278321en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/31231
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84883278321&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleIdentification of three novel natural product compounds that activate PXR and CAR and inhibit inflammationen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84883278321&origin=inwarden_US

Files

Collections